Article Text

Download PDFPDF
Hybrid closed-loop insulin delivery in young children with type one diabetes mellitus

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The world of type one diabetes mellitus and insulin therapy, pumps, blood sugar monitoring and glycaemic control is fast-growing. Assessing control is no longer simply measuring HbA1C. It’s very hard to keep up with the technology. The possible advantage of hybrid closed-loop therapy (an artificial pancreas) over sensor-augmented pump therapy in very young children with type one diabetes is unclear. Ware J et al (N Engl J Med 2022;386:209–219) have conducted a multicentre, randomised, crossover trial, in children with type one diabetes who were receiving insulin-pump therapy at seven centres across Austria, Germany, Luxembourg, and the UK. …

View Full Text


  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles